Prelude Capital Management’s Abeona Therapeutics ABEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $307K | Buy |
+54,134
| New | +$307K | 0.03% | 600 |
|
|
2021
Q2 | – | Sell |
-1,180
| Closed | -$55K | – | 1330 |
|
|
2021
Q1 | $55K | Buy |
+1,180
| New | +$55K | ﹤0.01% | 1037 |
|
|
2019
Q3 | – | Sell |
-2
| Closed | – | – | 1145 |
|
|
2019
Q2 | $0 | Sell |
2
-3
| -60% | – | ﹤0.01% | 1196 |
|
|
2019
Q1 | $1K | Sell |
5
-1
| -17% | -$200 | ﹤0.01% | 1297 |
|
|
2018
Q4 | $1K | Sell |
6
-81
| -93% | -$13.5K | ﹤0.01% | 1328 |
|
|
2018
Q3 | $28K | Buy |
87
+24
| +38% | +$7.72K | ﹤0.01% | 914 |
|
|
2018
Q2 | $25K | Buy |
63
+1
| +2% | +$397 | ﹤0.01% | 1038 |
|
|
2018
Q1 | $22K | Buy |
62
+14
| +29% | +$4.97K | ﹤0.01% | 1098 |
|
|
2017
Q4 | $19K | Sell |
48
-859
| -95% | -$340K | ﹤0.01% | 1014 |
|
|
2017
Q3 | $387K | Sell |
907
-958
| -51% | -$409K | 0.03% | 395 |
|
|
2017
Q2 | $298K | Buy |
1,865
+1,685
| +936% | +$269K | 0.03% | 412 |
|
|
2017
Q1 | $23K | Sell |
180
-20
| -10% | -$2.56K | ﹤0.01% | 1184 |
|
|
2016
Q4 | $24K | Sell |
200
-520
| -72% | -$62.4K | ﹤0.01% | 1228 |
|
|
2016
Q3 | $108K | Sell |
720
-480
| -40% | -$72K | 0.01% | 750 |
|
|
2016
Q2 | $71K | Sell |
1,200
-216
| -15% | -$12.8K | 0.01% | 831 |
|
|
2016
Q1 | $91K | Buy |
1,416
+216
| +18% | +$13.9K | 0.01% | 726 |
|
|
2015
Q4 | $101K | Buy |
1,200
+504
| +72% | +$42.4K | 0.02% | 754 |
|
|
2015
Q3 | $70K | Buy |
696
+576
| +480% | +$57.9K | 0.01% | 878 |
|
|
2015
Q2 | $15K | Buy |
+120
| New | +$15K | ﹤0.01% | 1404 |
|